PubRank

Association of the TNF-α G-308A polymorphism with TNF-inhibitor response in sarcoidosis.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 24558177)

Published in Eur Respir J on February 20, 2014

Authors

Petal A Wijnen1, Johanna P Cremers2, Patty J Nelemans3, Roel J Erckens4, Elske Hoitsma5, Tim L Jansen6, Otto Bekers1, Marjolein Drent7

Author Affiliations

1: Central Diagnostic Laboratory, Maastricht University Medical Centre, Maastricht, The Netherlands.
2: Dept of Interstitial Lung Diseases, Gelderse Vallei Hospital, Ede, The Netherlands.
3: Dept of Epidemiology, Maastricht University, Maastricht, The Netherlands.
4: Dept of Ophthalmology, Maastricht University Medical Centre, Maastricht, The Netherlands.
5: Dept of Neurology, Diaconessenhuis, Leiden, The Netherlands.
6: Dept of Rheumatology, University Medical Centre St. Radboud, Nijmegen, The Netherlands.
7: Dept of Interstitial Lung Diseases, Gelderse Vallei Hospital, Ede, The Netherlands Dept of Toxicology, Maastricht University, Maastricht, The Netherlands m.drent@maastrichtuniversity.nl.

Articles citing this ↘

Advances in the diagnosis and treatment of sarcoidosis. F1000Prime Rep (2014) 0.96

Identification of Immune-Relevant Factors Conferring Sarcoidosis Genetic Risk. Am J Respir Crit Care Med (2015) 0.92

Interleukin-12 family cytokines and sarcoidosis. Front Pharmacol (2014) 0.77

Granuloma genes in sarcoidosis: what is new? Curr Opin Pulm Med (2015) 0.76

Clinical highlights: messages from Munich. ERJ Open Res (2015) 0.75

Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics. Front Pharmacol (2017) 0.75

Adalimumab-induced pulmonary sarcoidosis not progressing upon treatment with etanercept. Z Rheumatol (2017) 0.75